875781-48-9 Usage
Uses
Used in Pharmaceutical Industry:
3-Amino-6-iodopyrazine-2-carboxylic acid is used as a synthetic intermediate for the development of pharmaceutical compounds. Its diverse functional groups allow for the creation of complex molecules with potential therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Amino-6-iodopyrazine-2-carboxylic acid is utilized as a building block in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Organic Chemistry Research:
3-Amino-6-iodopyrazine-2-carboxylic acid is employed as a versatile starting material in organic chemistry research, enabling the exploration of new reactions and the synthesis of novel organic compounds.
Used in Medicinal Chemistry:
Due to its potential biological activity, 3-Amino-6-iodopyrazine-2-carboxylic acid is investigated for applications in medicinal chemistry, where it may contribute to the discovery of new drugs and therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 875781-48-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,7,8 and 1 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 875781-48:
(8*8)+(7*7)+(6*5)+(5*7)+(4*8)+(3*1)+(2*4)+(1*8)=229
229 % 10 = 9
So 875781-48-9 is a valid CAS Registry Number.
InChI:InChI=1/C5H4IN3O2/c6-2-1-8-4(7)3(9-2)5(10)11/h1H,(H2,7,8)(H,10,11)
875781-48-9Relevant academic research and scientific papers
PYRAZINAMIDE COMPOUND
-
Page/Page column 25, (2010/04/23)
Disclosed is a pyrazinamide compound represented by the formula (1), a tautomer, stereoisomer or pharmaceutically acceptable salt thereof, or a solvate of the compound or the tautomer, stereoisomer or pharmaceutically acceptable salt thereof, which has an excellent GK-activating activity and is therefore useful as a medicinal agent. (1) wherein R1 represents a hydrogen atom, a C1-8 alkyl group, a C3-8 cycloalkyl group, a C2-9 heterocyclyl group, a phenyl group, a C1-9 heteroaryl group, a C7-14 arylalkyl group or the like; R2 represents a C1-8 alkyl group, a C2-9 heterocyclyl group, a phenyl group, a C1-9 heteroaryl group or the like; Ar represents a monocyclic or fused polycyclic C1-9 heteroaryl group represented by the formula (2) or a C2-9 heterocyclyl group represented by formula (2); Y represents -S-, -O-or -NH-; and Z represents -S-, -O- or -CH2-.
FUSED RING HETEROCYCLE KINASE MODULATORS
-
Page/Page column 108, (2008/06/13)
The present invention provides novel fused ring heterocycle kinase modulators and methods of using the novel fused ring heterocycle kinase modulators to treat diseases mediated by kinase activity.
